Favorable long-term outcome of nephrotic syndrome after allogeneic hematopoietic stem cell transplantation

Clinical Nephrology

Volumn 67, Issue 1, 2007, Pages 5-11

  Kemper, M J ^a   Gungor T ^b   Halter, J ^c   Schanz, U ^c   Neuhaus, Thomas J ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

CSA; GVHD; Hematopoietic stem cell transplantation; Long term out come; Nephrotic syndrome

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTINEOPLASTIC AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; ETOPOSIDE; FLUDARABINE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; STEROID; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADRENOLEUKODYSTROPHY; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; B CELL LEUKEMIA; CASE REPORT; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL FEATURE; COUGHING; CYTOTOXIC T LYMPHOCYTE; DISEASE EXACERBATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; GENERALIZED EDEMA; HEMORRHAGIC CYSTITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOALBUMINEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; LEG EDEMA; LONG TERM CARE; LOW DRUG DOSE; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MONOTHERAPY; MYELOABLATIVE CONDITIONING; NEPHROTIC SYNDROME; NEPHROTOXICITY; ONSET AGE; PROTEINURIA; REMISSION; TREATMENT OUTCOME; VIRUS REACTIVATION; WHOLE BODY RADIATION;

EID: 33847318812     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP67005     Document Type: Article

References (37)

1. Akar H, Keven K, Celebi H, Orhan D, Nergizoglu G, Erbay B, Tulunay O, Ozcan M, Erturk S. Nephrotic syndrome after allogeneic peripheral blood stem cell transplantation. J Nephrol. 2002; 15: 79-82.
2. Barbara JA, Thomas AC, Smith PS, Gillis D, Ho JO, Woodroffe AJ. Membranous nephropathy with graft-versus-host disease in a bone marrow transplant recipient. Clin Nephrol. 1992; 37: 115-118.
3. Bernis C, Camara R, Garcia Sanchez A, Martinez MA, Selgas R. Nephrotic syndrome in a bone marrow transplant recipient after cyclosporine withdrawal. Nephrol Dial Transplant. 2003; 18: 2457.
4. Bruijn JA, Hogendoorn PC, Corver WE, van den Broek LJ, Hoedemaeker PJ, Fleuren GJ. Pathogenesis of experimental lupus nephritis: a role for anti-basement membrane and anti-tubular brush border antibodies in murine chronic graft-versus-host disease. Clin Exp Immunol. 1990; 79: 115-122.
5. Bruijn JA, van Elven EH, Hogendoorn PC, Corver WE, Hoedemaeker PJ, Fleuren GJ. Murine chronic graft-versus-host disease as a model for lupus nephritis. Am J Pathol. 1988; 130: 639-641.
6. Chan GS, Lam MF, Au WY, Tse KC, Chan TM, Lai KN, Chan KW. IgA nephropathy complicating graft-versus-host disease, another nephropathy causing nephrotic syndrome after bone marrow transplantation. Histopathology. 2004; 45: 648-651.
7. Chien YH, Lin KH, Lee TY, Lu MY, Tsau YK. Nephrotic syndrome in a bone marrow transplant recipient without chronic graft-versus-host disease. J Formos Med Assoc. 2000; 99: 503-506.
8. Colombo AA, Rusconi C, Esposito C, Bernasconi P, Caldera D, Lazzarino M, Alessandrino EP. Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease. Transplantation. 2006; 81: 1087-1092.
9. Gleichmann H, Gleichmann E, Andre-Schwartz J, Schwartz RS. Chronic allogeneic disease. 3. Genetic requirements for the induction of glomerulonephritis. J Exp Med. 1972; 135: 516-532.
10. Gomez-Garcia P, Herrera-Arroyo C, Torres-Gomez A, Gomez-Carrasco J, Aljama-Garcia P, Lopez-Rubio F, Martinez-Guibelalde F, Fornes-Torres G, Rojas-Contreras R. Renal involvement in chronic graft-versus-host disease: a report of two cases. Bone Marrow Transplant. 1988; 3: 357-362.
11. Hiesse C, Goldschmidt E, Santelli G, Charpentier B, Machover D, Fries D. Membranous nephropathy in a bone marrow transplant recipient. Am J Kidney Dis. 1988; 11: 188-191.
12. Ikee R, Yamamoto K, Kushiyama T, Imakiire T Suzuki S, Miura S. Recurrent nephrotic syndrome associated with graft-versus-host disease. Bone Marrow Transplant. 2004; 34: 1005-1006.
13. Imai H, Oyama Y, Miura AB, Endoh M, Sakai H. Hematopoietic cell transplantation-related nephropathy in Japan. Am J Kidney Dis. 2000; 36: 474-480.
14. Kim KW, Yoon CH, Kay CS, Kim HJ, Suh KS, Kim SY, Park SY. Membranous nephropathy after allogeneic hematopoietic stem cell transplantation in a patient with aplastic anemia: a case report. J Korean Med Sci. 2003; 18: 287-289.
15. Kimura M, Pakabayashi T, Sata T, Mohri H, Shimada K. Membranous glomerulonephritis as an outstanding feature of renal lesions in autoimmune graft-vs-host F1 mice. Jpn J Exp Med. 1990; 60: 235-239.
16. Kimura S, Horie A, Hiki Y, Yamamoto C, Suzuki S, Kuroda J, Deguchi M, Kato G, Karasuno T, Hiraoka A, Yoshikawa T, Maekawa T. Nephrotic syndrome with crescent formation and massive IgA deposition following allogeneic bone marrow transplantation for natural killer cell leukemia/ lymphoma. Blood. 2003; 101: 4219-4221.
17. Kone BC, Whelton A, Santos G, Saral R, Watson AJ. Hypertension and renal dysfunction in bone marrow transplant recipients. Q J Med. 1988; 69: 985-995.
18. Lama G, Luongo I, Tirino G, Borriello A, Carangio C, Salsano ME. T lymphocyte populations and cytokines in childhood nephrotic syndrome. Am J Kidney Dis. 2002; 39: 958-965.
19. Lee GW, Lee JH, Kim SB, Yu ES, Lee JL, Ryu MH, Kim E, Choi SJ, Kim WK, Lee JS, Lee KH. Membranous glomerulopathy as a manifestation of chronic graft-versus-host disease after non-myeloablative stem cell transplantation in a patient with paroxysmal nocturnal hemoglobinuria. J Korean Med Sci. 2003; 18: 901-904.
20. Lin J, Markowitz GS, Nicolaides M, Hesdorffer CS, Appel GB, D'Agati VD, Savage DG. Membranous glomerulopathy associated with graft-versus-host disease following allogeneic stem cell transplantation. Report of 2 cases and review of the literature. Am J Nephrol. 2001; 21: 351-356.
21. Miyazaki Y, Mori Y, Kishimoto N, Matsumoto N, Zen K, Amakawa R, Kishimoto Y, Fukuhara S. Membranous nephropathy associated with donor lymphocyte infusion following allogencic bone marrow transplantation. Int J Hematol. 2003; 78: 262-265.
22. Morisada N, Okita S, Sato T, Miyaji R, Kamizono J, Shimono M, Osajima A, Kaizu K, Asayama K, Shirahata A. Girl with nephrotic syndrome after peripheral blood stem cell transplantation. Pediatr Int. 2004; 46: 480-483.
23. Nergizoglu G, Keven K, Ates K, Ustun C, Tulunay O, Beksac M, Karatan O, Ertug AE. Chronic graft-versus-host disease complicated by membranous glomerulonephritis. Nephrol Dial Transplant. 1999; 14: 2461-2463.
24. Ohsawa I, Ohi H, Fujita T, Endo M, Ito T, Sawada U, Yamaguchi Y. Glomerular and extraglomerular immune complex deposits in a bone marrow transplant recipient. Am J Kidney Dis. 2000; 36: E3.
25. Rao PS. Nephrotic syndrome in patients with peripheral blood stem cell transplant. Am J Kidney Dis. 2005; 45: 780-785.
26. Reddy P. Pathophysiology of acute graft-versus-host disease. Hematol Oncol. 2003; 21: 149-161.
27. Romagnani P, Lazzeri E, Mazzinghi B, Lasagni L, Guidi S, Bosi A, Cirami C, Salvadori M. Nephrotic syndrome and renal failure after allogeneic stem cell transplantation: novel molecular diagnostic tools for a challenging differential diagnosis. Am J Kidney Dis. 2005; 46: 550-556.
28. Rossi L, Cardarelli F, Pampa ML, Buzio C, Olivetti G. Membranous glomerulonephritis after hematopoietic cell transplantation for multiple myeloma. Nephron. 2001; 88: 260-263.
29. Sato Y, Hara S, Fujimoto S, Yamada K, Sakamaki H, Eto T. Minimal-change nephrotic syndrome after allogenic hematopoietic stem cell transplantation. Intern Med. 2004; 43: 512-515.
30. Seconi J, Watt V, Ritchie DS. Nephrotic syndrome following allogeneic stem cell transplantation associated with increased production of TNF-alpha and interferon-gamma by donor T cells. Bone Marrow Transplant. 2003; 32: 447-450.
31. Srinivasan R, Balow JE, Sabnis S, Lundqvist A, Igarashi T, Takahashi Y, Austin H, Tisdale J, Barrett J, Geller N, Childs R. Nephrotic syndrome: an under-recognised immune-mediated complication of non-myeloablative allogeneic hematopoietic cell transplantation. Br J Hematol. 2005; 131: 74-79.
32. Stevenson WS, Nankivell BJ, Hertzberg MS. Nephrotic syndrome after stem cell transplantation. Clin Transplant. 2005; 19: 141-144.
33. Suehiro T, Masutani K, Yokoyama M, Tokumoto M, Tsuruya K, Fukuda K, Kanai H, Katafuchi R, Nagatoshi Y, Hirakata H. Diffuse proliferative glomerulorephritis after bone marrow transplantation. Clin Nephrol. 2002; 58: 231-237.
34. Suranyi MG, Guasch A, Hall BM, Myers BD. Elevated levels of tumor necrosis factor-alpha in the nephrotic syndrome in humans. Am J Kidney Dis. 1993; 21: 251-259.
35. Tsutsumi C, Miyazaki Y, Fukushima T, Yoshida S, Taguchi J, Miyake C, Miyazaki M, Kohno S, Jinnai I, Tomonaga M. Membranous nephropathy, after allogeneic stem cell transplantation: report of 2 cases. Int J Hematol. 2004; 79: 193-197.
36. Walker JV, Morich D, Anasetti C. Minimal-change nephrotic syndrome after cyclosporine withdrawal in a marrow transplant recipient. Am J Kidney Dis. 1995; 26: 532-534.
37. Yorioka N, Taniguchi Y, Shimote K, Komo T, Yamakido M, Hyodo H, Kimura A, Taguchi T. Membranous nephropathy with chronic graft-versus-host disease in a bone marrow transplant recipient. Nephron. 1998; 80: 371-372.